Cellebrite DI (NASDAQ:CLBT) Earns Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research note published on Friday morning,Benzinga reports. They currently have a $24.00 target price on the stock. A number of other brokerages have also recently issued reports on CLBT. JPMorgan Chase & Co. decreased their target […]
Needham & Company LLC reiterated their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research note published on Friday morning,Benzinga reports. They currently have a $24.00 target price on the stock. A number of other brokerages have also recently issued reports on CLBT. JPMorgan Chase & Co. decreased their target […]
